InsidersTradesSigma
Track the IMMURON LIMITED stock price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on the AU market, under the authority of ASX. Market capitalisation: €11m. The latest transaction was filed on 15 July 2026 (Change in Substantial Holding). Among the most active insiders: listed in Annexure A (Group Entity),(together BNY Group). Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IMMURON LIMITED is an Australian Securities Exchange listed company focused on developing treatments for intestinal diseases. The company emphasizes research and innovation in the healthcare sector.